« Zurück
Startseite /
TRAIL R3 (Extracellular Domain - 2) Blocking Peptide - 50 µg

TRAIL R3 (Extracellular Domain - 2) Blocking Peptide - 50 µg

ArtNr	LEIN-D265-50ug
Hersteller	Leinco Technologies
Menge	50 ug
Kategorie	Oncology Neuroscience Neuroinflammation Metabolism Diabetes By Cell Type Peptides & Proteins Cell Biology Obesity Cell Culture Cytokines Cell Status Necrosis Apoptosis Peptides
Typ	Peptides
Specific against	Human (Homo sapiens)
Citations	1. Fornace AJ Jr. et al. (1999) Oncogene 18: 4153 2. Büchler MW et al. (2001) Anticancer Res. 21: 3153 3. Smith CA et al. (1997) J Exp Med. 186: 1165
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Versandbedingung	Raumtemperatur
Lieferbar
Manufacturer - Category	Control Peptides
Manufacturer - Targets	TNF-Related Apoptosis-Inducing Ligand Receptor 3
Country of Origin	USA
Shipping Temperature	Next Day Ambient
Storage Conditions	Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Product Description	TNF-related apoptosis-inducing ligand receptor 3 (TRAIL R3) is an antagonist decoy receptor1 that can inhibit TRAIL-induced apoptosis.2 TRAIL R3 is a plasma membrane-bound protein capable of high affinity interaction with the TRAIL ligand.3
Background	TNF-related apoptosis-inducing ligand receptor 3 (TRAIL R3) is an antagonist decoy receptor¹ that can inhibit TRAIL-induced apoptosis.² TRAIL R3 is a plasma membrane-bound protein capable of high affinity interaction with the TRAIL ligand.³
PubMed	TNF-Related Apoptosis-Inducing Ligand Receptor 3
Amino acid location	This peptide sequence is located at amino acids 111 to 123 of Human DcR1 protein.
Concentration	0.2 mg/ml
Formulation	This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Additional Information	Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Keywords	Blocking Peptide, TNF-Related Apoptosis-Inducing Ligand Receptor 3, TRID, TNFRSF10C, CD263, DCR1, LIT, MGC149501, MGC149502, TRAIL R3, Human, TRAIL R3 (Extracellular Domain - 2) Blocking Peptide

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkt-Datenblatt anfordern

Sicherheitsdatenblatt anfordern

Einfache Bestellung Periodische Bestellung

Menge: 50 ug

lieferbar

Lieferung vsl. bis 16.10.2025

Express-Lieferung: 3 Tage sparen

Vergleichen

Auf den Wunschzettel

Angebot anfordern